The invention relates to methods of optimizing gamma carboxylation of a vitamin K-dependent protein, methods of generating fully gamma carboxylated vitamin K-dependent protein, and compositions comprising chimeric nucleic acids and proteins for use in treatment of vitamin K-dependent disease states.

 
Web www.patentalert.com

> Nucleic acid encoding calcyon, a D-1 like dopamine receptor activity modifying protein

~ 00348